Hormone Replacement Therapy Market Revenue Share & Opportunity Status during 2018-2028
Verfasser: ashwani_kailiya on Wednesday, 19 February 2020The hormone replacement therapy market is foreseen to expand at a significant pace with sales of hormone replacement therapy products crossing US$ 12,000 Mn by 2019 end. Rising incidences of osteoporosis fractures coupled with growing menopause rates among women have remained instrumental in driving the demand for hormone replacement therapy. Fact.MR envisages that the demand for hormone replacement therapy is projected to expand at a CAGR of 6.0% in terms of value throughout the period of forecast, 2018-2028.
The hormone replacement therapy market report highlights the following players:
- Novartis AG
- Novo Nordisk A/S
- Teva Pharmaceuticals
- Mylan N.V
- Others
The hormone replacement therapy market report examines the operating pattern of each player – new product launches, partnerships, and acquisitions – has been examined in detail.